JP2022529321A5 - - Google Patents

Info

Publication number
JP2022529321A5
JP2022529321A5 JP2021559729A JP2021559729A JP2022529321A5 JP 2022529321 A5 JP2022529321 A5 JP 2022529321A5 JP 2021559729 A JP2021559729 A JP 2021559729A JP 2021559729 A JP2021559729 A JP 2021559729A JP 2022529321 A5 JP2022529321 A5 JP 2022529321A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound according
formula
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559729A
Other languages
English (en)
Japanese (ja)
Other versions
JP7661235B2 (ja
JP2022529321A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029149 external-priority patent/WO2020219464A1/en
Publication of JP2022529321A publication Critical patent/JP2022529321A/ja
Publication of JP2022529321A5 publication Critical patent/JP2022529321A5/ja
Priority to JP2025060882A priority Critical patent/JP2025106352A/ja
Application granted granted Critical
Publication of JP7661235B2 publication Critical patent/JP7661235B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559729A 2019-04-22 2020-04-21 環状リン酸エステル化合物 Active JP7661235B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025060882A JP2025106352A (ja) 2019-04-22 2025-04-02 環状リン酸エステル化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962837137P 2019-04-22 2019-04-22
US62/837,137 2019-04-22
PCT/US2020/029149 WO2020219464A1 (en) 2019-04-22 2020-04-21 Cyclic phosphate compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025060882A Division JP2025106352A (ja) 2019-04-22 2025-04-02 環状リン酸エステル化合物

Publications (3)

Publication Number Publication Date
JP2022529321A JP2022529321A (ja) 2022-06-21
JP2022529321A5 true JP2022529321A5 (cg-RX-API-DMAC7.html) 2023-04-26
JP7661235B2 JP7661235B2 (ja) 2025-04-14

Family

ID=72941350

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021559729A Active JP7661235B2 (ja) 2019-04-22 2020-04-21 環状リン酸エステル化合物
JP2025060882A Pending JP2025106352A (ja) 2019-04-22 2025-04-02 環状リン酸エステル化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025060882A Pending JP2025106352A (ja) 2019-04-22 2025-04-02 環状リン酸エステル化合物

Country Status (9)

Country Link
US (1) US20220220145A1 (cg-RX-API-DMAC7.html)
EP (1) EP3966221A4 (cg-RX-API-DMAC7.html)
JP (2) JP7661235B2 (cg-RX-API-DMAC7.html)
KR (2) KR20260062967A (cg-RX-API-DMAC7.html)
CN (1) CN113939526A (cg-RX-API-DMAC7.html)
AU (1) AU2020263283B2 (cg-RX-API-DMAC7.html)
CA (1) CA3136954A1 (cg-RX-API-DMAC7.html)
MX (1) MX428883B (cg-RX-API-DMAC7.html)
WO (1) WO2020219464A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019207626B2 (en) 2018-01-10 2023-10-05 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
MX428883B (es) * 2019-04-22 2025-11-13 Ligand Pharm Inc Compuestos ciclicos de fosfato
WO2021011692A1 (en) 2019-07-17 2021-01-21 Nucorion Pharmaceuticals, Inc. Cyclic deoxyribonucleotide compounds
EP4143199B1 (en) * 2020-04-21 2025-11-19 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
WO2021216431A1 (en) * 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Benzyloxy phosph(on)ate compounds
JP7699205B2 (ja) * 2020-10-21 2025-06-26 リガンド・ファーマシューティカルズ・インコーポレイテッド 抗ウイルスプロドラッグ化合物
US20240294565A1 (en) * 2021-05-17 2024-09-05 Ligand Pharmaceuticals Incorporated Unnatural configuration nucleotide prodrug compounds
CN118005694B (zh) * 2023-01-06 2025-04-22 北京双鹤润创科技有限公司 一种环状核苷类似物及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6023120B2 (ja) * 1979-08-13 1985-06-05 キッコーマン株式会社 アデノシン−3′,5′−環状リン酸アルキルトリエステルの製造法
DE3027279A1 (de) * 1980-07-18 1982-05-06 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5866548A (en) * 1993-04-09 1999-02-02 The Regents Of The University Of California Caged membrane-permeant inositol phosphates
US5693521A (en) * 1993-04-09 1997-12-02 The Regents Of The University Of California Membrane-permeant second messengers
US5834436A (en) * 1993-04-09 1998-11-10 The Regents Of The University Of California Membrane-permeant second messengers
WO2007027248A2 (en) * 2005-05-16 2007-03-08 Valeant Research & Development 3', 5' - cyclic nucleoside analogues for treatment of hcv
US8173621B2 (en) * 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8772474B2 (en) * 2010-12-22 2014-07-08 Alios Biopharma, Inc. Cyclic nucleotide analogs
WO2013177195A1 (en) * 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
ES2674980T3 (es) * 2012-10-08 2018-07-05 Idenix Pharmaceuticals Llc Análogos de 2'-cloro nucleósidos para infección por VHC
JP2016501200A (ja) * 2012-11-19 2016-01-18 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. ウイルス性疾患を処置するための2−アルキニル置換ヌクレオシド誘導体
US9243022B2 (en) * 2012-12-21 2016-01-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
EP3131914B1 (en) * 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
EP3471737B1 (en) * 2016-06-20 2025-06-04 Merck Sharp & Dohme LLC Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases
CN111491634A (zh) 2017-07-31 2020-08-04 詹纽瑞治疗公司 有机磷酸酯衍生物
CN111801339B (zh) 2018-01-19 2025-06-24 纽科利制药公司 5-氟尿嘧啶化合物
AU2019227986A1 (en) * 2018-03-02 2020-10-08 January Therapeutics, Inc. Nanoparticle compositions
MX428883B (es) * 2019-04-22 2025-11-13 Ligand Pharm Inc Compuestos ciclicos de fosfato

Similar Documents

Publication Publication Date Title
CN109528721B (zh) 联合治疗
JP2020169171A5 (cg-RX-API-DMAC7.html)
RU2009102278A (ru) Модуляторы рецептора s1p для лечения рассеянного склероза
FI3518960T3 (fi) Annostusohjelma kontrolloidusti vapautuvalle PTH-yhdisteelle
RU97115713A (ru) Соединения, содержащие бензопиран и способ их применения
CN1129397A (zh) 治疗眼炎的含3-苯甲酰基苯乙酸衍生物的局部给药组合物
JP2022137237A5 (cg-RX-API-DMAC7.html)
JP2002508302A (ja) 鎮痛薬として有用なα−アミノアミド誘導体
RU2012110380A (ru) Новое производное 5-фторурацила
JP2023546565A5 (cg-RX-API-DMAC7.html)
JP2012525437A5 (cg-RX-API-DMAC7.html)
RU2005121927A (ru) Производные безводного кристаллического азидоцитозинполусульфата
MX2022011242A (es) Inmunomodulación de o-het/aril azálidos.
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
US20130158123A1 (en) Method of treating non-alcoholic fatty liver disease and steatohepatitis
RU2008131907A (ru) Новые соединения
JP2023522866A5 (cg-RX-API-DMAC7.html)
MX2024002892A (es) Azalidos inmunomoduladores.
JP2009507810A (ja) 自己免疫性疾患の処置
RU2011129771A (ru) Противораковые соединения
US4148911A (en) Method of treating respiratory disorders
RU2006126828A (ru) Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза
KR20130098885A (ko) 디아릴 술피드 유도체의 투여 요법
RU2021129954A (ru) Циклические фосфатные соединения
RU2004109817A (ru) Производные аминопиррола в качестве противовоспалительных средств